Pros and cons of CSII and CGM technology among subjects with T2D
| Pros | Cons | |
|---|---|---|
| Both for CSII and CGM | Improvement of HbA1c level in short and long-term | Only for selected patients suitable for technologyNecessity of time for specific trainingNeed for healthcare provider team trained to technology use |
| Usually discrete and easy to wearImproved quality of lifeUseful and effective in case of pregnancy and its planning | Risk of skin reactions at the insertion siteRisk of non-adherence or early discontinuation of technology use | |
| Short term | ||
| CGM specific issues | Reduction of hypoglycemic eventsComplete glucose profilesNo calibration needed for some devices | Risk of long term burn-out by alarmsBig amount of data to be interpretedCalibration needed for some devices |
| CSII specific issues | Tailored insulin therapyEfficacy both in obese and in non-obese patients |
long term cost must be evaluated in cost effectiveness studies, to evaluate if long term reduction of diabetes related complications could compensate initial costs
AMB and AL conceived the idea of the manuscript and designed the project; AA, AC, AMB and EP organized the collected data to review; EP wrote the first draft of the manuscript with the supervision of AMB, AC and AL; AC, AMB and AL contributed to work design and critically reviewed the manuscript. All authors discussed the project, contributed to manuscript revision, read and approved the submitted version.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2020.